Johns Hopkins University at AAPS 2026 PharmSci 360
Oct 25–28, 2026 New Orleans, LA ~4k attendees Website
Johns Hopkins University brings 3 presentations to AAPS 2026 PharmSci 360 in New Orleans. Its program centres on the move toward drug development without animal testing. Its work also includes targeted liposomes carrying a HIF-1 alpha inhibitor for cancers linked to low oxygen.
| Organization | AAPS 2026 PharmSci 360 Attendance |
|---|---|
Johns Hopkins University Baltimore, MD | |
Poster Mon Oct 26 3:30pm–4:30pm Targeted Liposomal Delivery of the HIF-1α Inhibitor for Hypoxia-Associated Cancer Therapy Session Wed Oct 28 3:00pm–4:00pm Hot Topic: The Countdown to Post-Animal Drug Development: Disruptors on the Ground Preclinical, clinical and translational sciences Talk Wed Oct 28 3:40pm–4:00pm Panel Discussion Preclinical, clinical and translational sciences |
Instantly find 20 buyers from Johns Hopkins University
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction